Abstract Abstract #4013 [Purpose]
 Although “hardness” is a characteristic of invasive carcinomas, it was not given much importance until now because of its poor quantitative nature and reproducibility. However, due to the development of real-time tissue elastography (EG), the objective measurement of “hardness” is now possible. Moreover, we examined whether mammography (MMG) + B-mode ultrasound (US) in combination with EG improves diagnosability.
 [Subjects and methods]
 One hundred and seventy-seven patients with mass-image-forming lesions (135 benign, 42 malignant) whose tissues were diagnosed by core and mammotome biopsies from Oct 2007 to May 2008 were included in the study. Instruments used were Hitachi EUB-8500 and HV-900. The hardness is scored on a scale 1 to 5. Score 1: Distortion appears in the image of the entire low echo tumors, Score 2: Image of most of tumors are distorted but no distortion is seen in certain areas, Score 3: Distortion appears only in the peripheral areas, Score 4: No distortion appears in the entire tumors, and Score 5: No distortion appears even in the peripheral areas. The cases over score 4 are assumed to be malignant. US of category 4 or more, and MMG of category 3 or more were evaluated as malignant.
 [Results]
 In 57 patients with lesions of less than 1.1 cm (50 benign, 7 malignant), US + MMG showed sensitivity and specificity of 71.4% and 88.0%, respectively, whereas US + MMG + EG showed sensitivity and specificity of 100% and 80.8%. Moreover, when EG was combined with conventional methods, sensitivity increased from 71.4% to 100%. On the other hand, in 120 patients with lesions of 1.1 cm or more (85 benign, 35 malignant), US + MMG showed sensitivity and specificity of 100% and 55.3%, respectively, whereas US + MMG + EG showed sensitivity and specificity of 100% and 61.2%. There were no significant differences in sensitivity and specificity between the 2 methods, and no additional advantages were observed when EG was used.
 [Conclusions]
 Thus, in this study sensitivity could be increased by EG for tumors with a diameter of less than 1.1 cm. Therefore, it was suggested that biopsy may be omissible for low EG scores. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 4013.